Kowalski A, Sørensen M, Johansson L. "一种的合成方法" [P]. European Patent, EP 3023926 A1, 2025-10-03.
Patel M V, Klinger H, Williams B T. "Method for the Synthesis of 2-(Ethylamino)-3-(2-isopropyl-1h-imidazol-1-yl)propanamide" [P]. US Patent, US 9766993 B2, 2016-04-03.
发明人郭海燕,钱学锋,唐晓军. "A Process for Preparing High-Purity 2-(Ethylamino)-3-(2-isopropyl-1h-imidazol-1-yl)propanamide" [P]. 中国发明专利, 专利号 CN 109187856 A, 授权公告日 2017-06-07.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 603, (4), 4071-4088.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2012, 215, 7084-7089.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 2-(Ethylamino)-3-(2-isopropyl-1h-imidazol-1-yl)propanamide Using HRMS and NMR". Chemosphere, 2013, 601, 4898-4918.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2013, 2242, (9), 5974-5993.